AI in Healthcare Platforms: What's Production-Ready and What's Still Early

Most enterprise AI advice assumes an error budget. Summarize a hundred support tickets, get four wrong, and the aggregate value is still positive.

Clinical data platforms don't work that way, and it isn't primarily about regulation. It's that the output is consumed by people making decisions they can't easily audit. A patient comparing transplant centers cannot evaluate whether the summary reflects the underlying data. A clinician reviewing a cohort assumes the numbers came from the registry. When an AI-produced figure is wrong there, the error is invisible at the moment it matters, and it inherits the credibility of the platform it appears in.

So the readiness question is not whether a capability works most of the time. It's whether a failure is detectable by whoever is looking at it.

What that test admits

Structured extraction from documents. Pulling defined fields out of clinical forms, scanned records or narrative reports into a schema. Production-ready because it's verifiable: extracted values can be checked against the source, against type and range constraints, and against internal consistency, with low-confidence records routed to a human. A wrong extraction is checkable in a way a wrong summary is not.

Anomaly detection in registry submissions. Statistical models flagging submissions that deviate from expected distributions — a center whose outcomes shift sharply, a field whose completeness drops after a system change. Effective and low-risk, because the output is a flag for human review rather than a conclusion. A false positive costs someone twenty minutes. Unglamorous, and where most of the near-term value sits.

Semantic search over document corpora. Finding material in research libraries, protocols and internal guidance. Ready for the same reason: the user sees the source and judges relevance directly.

The pattern holds across all three. The human keeps the judgment, the AI reduces the search space, and an error surfaces immediately rather than propagating.

What isn't ready

Generated narrative over outcome data. The most-requested capability and the one to resist longest. Ask a model to summarize center performance from registry data and it produces clean, confident prose. The failure isn't fabrication of the obvious kind. The model describes a difference between two centers without accounting for risk adjustment. It reports a rate from a cohort of nine as though it were comparable to a cohort of four hundred. It uses causal language about an association.

Each is a statistical error a trained analyst avoids automatically, and each reads as authoritative. There's no visual cue. A chart with a wide confidence interval at least shows the interval; a sentence saying Center A performed better than Center B shows nothing.

Where narrative is genuinely required, let the model do language and not arithmetic: every number and comparison comes from a validated computation in the data layer, and the model fills a constrained template around figures it cannot alter. Less impressive than the demo, and deployable.

Anything positioned as clinical decision support. Crosses into regulatory territory and requires explainability current generative systems don't provide. Organizations arrive here accidentally, when a tool built for internal analysis starts informing care decisions because it turned out to be useful. The classification depends on how the output is used, not how it was designed, so the drift is worth watching for deliberately.

Anything requiring PHI to leave your control boundary. Solvable, but it's an architecture decision with contract implications rather than a setting. Confirm where inference runs, whether a BAA covers it, and whether prompts and outputs are retained or trained on. Vendor answers on retention are often less specific than they first sound.

Evaluating a vendor

Ask what the system does when it is uncertain. A product with a real confidence measure and a defined route for low-confidence output was built by people who understood clinical review. If everything comes back with the same assurance, a reviewer has no mechanism for catching the cases that need catching.

Ask them to run against your data, with your edge cases — small cohorts, incomplete records, centers that changed reporting practices mid-year. Every product performs on clean data. A vendor who won't run that test is telling you something about the result.

Ask how numbers in any generated output are produced. If the model derives them from source data, that's the failure mode above, and prompt engineering doesn't fix it. If they come from a validated computation and the model only handles language, that's a team that has thought about statistical integrity.

The organizations getting real value from AI in this space are mostly doing unglamorous things — extraction, flagging, search — and doing them carefully. What holds back the more ambitious applications is less the maturity of the models than the requirement that a wrong answer be catchable by the person reading it.